The funder's mission is to improve outcomes for patients with advanced prostate cancer and to advance research, innovation, clinical expertise, and education for healthcare professionals in Latin America.
The grant program initiated by Pfizer and BMS aims to foster independent medical education on the oral anticoagulant treatment of patients suffering from atrial fibrillation and/or venous thromboembolism. It encourages the submission of grant applications that are committed to leveraging innovative data and employing diverse content delivery mechanisms, including an omnichannel approach, to elevate the understanding and management of these conditions among healthcare professionals.